Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on August 3, 2026

Aug. 3, 2026

Palomino Laboratories Completes Vega Links Acquisition and Strengthens Technology Leadership to Accelerate Next-Generation AI Interconnect Development

Indeterminate GlobeNewswire

Aug. 3, 2026

Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease

Indeterminate GlobeNewswire

Aug. 3, 2026

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

Indeterminate GlobeNewswire

Aug. 3, 2026

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

Indeterminate GlobeNewswire

Aug. 3, 2026

Aurora Mobile's GPTBots.ai Launches LoopAgent: Production-Grade Execution That Runs Complex Tasks End-to-End

Indeterminate GlobeNewswire

Aug. 3, 2026

Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für Juli 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt

Indeterminate GlobeNewswire

Aug. 3, 2026

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for July 2026 of its Virtune Crypto Altcoin Index ETP

Indeterminate GlobeNewswire

Aug. 3, 2026

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för juli 2026 av Virtune Crypto Altcoin Index ETP

Indeterminate GlobeNewswire

Aug. 3, 2026

Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Supernus Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

Indeterminate GlobeNewswire

Aug. 3, 2026

Diginex Announces Secured US$70 Million Funding Commitments and Extension of Long-Stop Date for Proposed Acquisition of Resulticks

Indeterminate GlobeNewswire

Aug. 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Indeterminate GlobeNewswire

Aug. 3, 2026

BioNTech ernennt Dr. Guido Oelkers zum neuen Vorstandsvorsitzenden

Indeterminate GlobeNewswire

Aug. 3, 2026

BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer

Indeterminate GlobeNewswire

Aug. 3, 2026

Interim Results from a Clinical Study Evaluating the Impact of Virtual Lactation Support through SimpliFed on Maternal Health and Breastfeeding Success Outcomes Released at Pediatrics Academic Societies Conference

Indeterminate GlobeNewswire

Aug. 3, 2026

Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy for the Treatment of Peanut Allergy

Indeterminate GlobeNewswire

Aug. 3, 2026

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

Indeterminate GlobeNewswire

Aug. 3, 2026

Revenium Launches ‘Guardrails’ for Real-Time AI Spend and Model Use Enforcement

Indeterminate GlobeNewswire

Aug. 3, 2026

1Spatial by VertiGIS and INDIGITAL Partner to Bring Automated GIS Data Integrity to NG911

Indeterminate GlobeNewswire